AWM
NVO

Atticus Wealth Management’s Novo Nordisk NVO Stock Holding History

Atticus Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-946
Closed -$65.3K – 481
2025
Q2 		$65.3K Hold
946
– – 0.02% 286
2025
Q1 		$65.7K Hold
946
– – 0.02% 207
2024
Q4 		$81.4K Sell
946
-919
-49% -$99.4K 0.03% 188
2024
Q3 		$222K Sell
1,865
-10
-0.5% -$1.33K 0.07% 113
2024
Q2 		$268K Sell
1,875
-12
-0.6% -$1.59K 0.09% 99
2024
Q1 		$242K Sell
1,887
-2,243
-54% -$267K 0.08% 114
2023
Q4 		$427K Sell
4,130
-774
-16% -$76.5K 0.15% 78
2023
Q3 		$446K Buy
4,904
+1,462
+42% +$129K 0.17% 78
2023
Q2 		$279K Buy
3,442
+2,546
+284% +$208K 0.1% 107
2023
Q1 		$71.3K Hold
896
– – 0.03% 209
2022
Q4 		$60.6K Hold
896
– – 0.02% 230
2022
Q3 		$50K Hold
896
– – 0.02% 230
2022
Q2 		$50K Buy
896
+788
+730% +$43.7K 0.02% 251
2022
Q1 		$6K Buy
+108
New +$5.54K ﹤0.01% 451

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Atticus Wealth Management's NVO Position: Q3 2025 in Review

Atticus Wealth Management sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 946 shares — an estimated $65.3K sold.

Atticus Wealth Management first reported a position in NVO in Q1 2022 and held it in 14 quarters. The position peaked at $446K in Q3 2023. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Atticus Wealth Management reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Atticus Wealth Management sold 946 Novo Nordisk shares in Q3 2025, an estimated $65.3K.
  • Atticus Wealth Management first reported a position in Novo Nordisk in Q1 2022 and held it in 14 quarters.
  • Atticus Wealth Management's Novo Nordisk position peaked at $446K in Q3 2023.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Atticus Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.